132 related articles for article (PubMed ID: 20826215)
1. Prokaryotic expression, refolding, and purification of functional human vascular endothelial growth factor isoform 165: purification procedures and refolding conditions revisited.
Lee IL; Li PS; Yu WL; Shen HH
Protein Expr Purif; 2011 Mar; 76(1):54-8. PubMed ID: 20826215
[TBL] [Abstract][Full Text] [Related]
2. Refolding and purification of recombinant human VEGF-121 expressed as inclusion bodies in Escherichia coli.
Hu ZM; Ma L; Zhou MQ; Gao JM; Wang XN
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1083-6. PubMed ID: 16939889
[TBL] [Abstract][Full Text] [Related]
3. High-yield expression of human vascular endothelial growth factor VEGF(165) in Escherichia coli and purification for therapeutic applications.
Pizarro SA; Gunson J; Field MJ; Dinges R; Khoo S; Dalal M; Lee M; Kaleas KA; Moiseff K; Garnick S; Reilly DE; Laird MW; Schmelzer CH
Protein Expr Purif; 2010 Aug; 72(2):184-93. PubMed ID: 20302942
[TBL] [Abstract][Full Text] [Related]
4. Expression and characterization of human vascular endothelial growth factor (VEGF165) in insect cells.
Lee GY; Jung WW; Kang CS; Bang IS
Protein Expr Purif; 2006 Apr; 46(2):503-9. PubMed ID: 16289914
[TBL] [Abstract][Full Text] [Related]
5. [Stable expression of rhVEGF165 in Chinese hamster ovary cells].
Zhang G; Zhang H; Nian W; Sun J
Sheng Wu Gong Cheng Xue Bao; 2011 Jun; 27(6):935-42. PubMed ID: 22034823
[TBL] [Abstract][Full Text] [Related]
6. On-column refolding purification of DT389-hIL13 recombinant protein expressed in Escherichia coli.
Sun W; Dai X; Zheng Y; Wang J; Hou L; Du J; Hu HG
Protein Expr Purif; 2011 Jan; 75(1):83-8. PubMed ID: 20851185
[TBL] [Abstract][Full Text] [Related]
7. Purification and refolding of vascular endothelial growth factor-B.
Scrofani SD; Fabri LJ; Xu P; Maccarone P; Nash AD
Protein Sci; 2000 Oct; 9(10):2018-25. PubMed ID: 11106176
[TBL] [Abstract][Full Text] [Related]
8. High-pressure refolding of human vascular endothelial growth factor (VEGF) recombinantly expressed in bacterial inclusion bodies: refolding optimization, and feasibility assessment.
Cothran A; St John RJ; Schmelzer CH; Pizarro SA
Biotechnol Prog; 2011; 27(5):1273-81. PubMed ID: 21608142
[TBL] [Abstract][Full Text] [Related]
9. Overproduction of recombinant human VEGF (vascular endothelial growth factor) in Chinese hamster ovary cells.
Lee SB; Park JS; Lee S; Park J; Yu S; Kim H; Kim D; Byun TH; Baek K; Ahn YJ; Yoon J
J Microbiol Biotechnol; 2008 Jan; 18(1):183-7. PubMed ID: 18239438
[TBL] [Abstract][Full Text] [Related]
10. Expression, purification, and refolding of a recombinant human bone morphogenetic protein 2 in vitro.
Zhang Y; Ma Y; Yang M; Min S; Yao J; Zhu L
Protein Expr Purif; 2011 Feb; 75(2):155-60. PubMed ID: 20691269
[TBL] [Abstract][Full Text] [Related]
11. Cloning, large-scale production, and purification of active dimeric rat vascular endothelial growth factor (rrVEGF-164).
Geutjes PJ; Nillesen ST; Lammers G; Daamen WF; van Kuppevelt TH
Protein Expr Purif; 2010 Jan; 69(1):76-82. PubMed ID: 19733244
[TBL] [Abstract][Full Text] [Related]
12. Purification and renaturation of recombinant human lymphotoxin (tumour necrosis factor beta) expressed in Escherichia coli as inclusion bodies.
Jin H; Uddin MS; Huang YL; Teo WK
J Chem Technol Biotechnol; 1994 Jan; 59(1):67-72. PubMed ID: 7764497
[TBL] [Abstract][Full Text] [Related]
13. Prokaryotic expression, purification and activity assay of recombinant vascular endothelial growth factor.
Yang P; Wang KZ; Shi ZB; Dang XQ; Yu PB; Wang CS; Gong FL
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1263-8. PubMed ID: 16982431
[TBL] [Abstract][Full Text] [Related]
14. Renaturation, purification and characterization of streptokinase expressed as inclusion body in recombinant E. coli.
Cherish Babu PV; Srinivas VK; Krishna Mohan V; Krishna E
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(2):218-26. PubMed ID: 17981102
[TBL] [Abstract][Full Text] [Related]
15. Expression of biologically active isoforms of the tumor angiogenesis factor VEGF in Escherichia coli.
Siemeister G; Schnurr B; Mohrs K; Schächtele C; Marmé D; Martiny-Baron G
Biochem Biophys Res Commun; 1996 May; 222(2):249-55. PubMed ID: 8670191
[TBL] [Abstract][Full Text] [Related]
16. Optimized procedure for renaturation of recombinant human bone morphogenetic protein-2 at high protein concentration.
Vallejo LF; Rinas U
Biotechnol Bioeng; 2004 Mar; 85(6):601-9. PubMed ID: 14966801
[TBL] [Abstract][Full Text] [Related]
17. Bacterial fermentation of recombinant major wasp allergen Antigen 5 using oxygen limiting growth conditions improves yield and quality of inclusion bodies.
Kischnick S; Weber B; Verdino P; Keller W; Sanders EA; Anspach FB; Fiebig H; Cromwell O; Suck R
Protein Expr Purif; 2006 Jun; 47(2):621-8. PubMed ID: 16495080
[TBL] [Abstract][Full Text] [Related]
18. Expression, purification, and refolding of biologically active Acinetobacter baumannii OmpA from Escherichia coli inclusion bodies.
McConnell MJ; Pachón J
Protein Expr Purif; 2011 May; 77(1):98-103. PubMed ID: 21130880
[TBL] [Abstract][Full Text] [Related]
19. Refolding and purification of recombinant human PDE7A expressed in Escherichia coli as inclusion bodies.
Richter W; Hermsdorf T; Kronbach T; Dettmer D
Protein Expr Purif; 2002 Jun; 25(1):138-48. PubMed ID: 12071709
[TBL] [Abstract][Full Text] [Related]
20. Recombinant murine growth hormone from E. coli inclusion bodies: expression, high-pressure solubilization and refolding, and characterization of activity and structure.
Fradkin AH; Boand CS; Eisenberg SP; Rosendahl MS; Randolph TW
Biotechnol Prog; 2010; 26(3):743-9. PubMed ID: 20196161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
